The Insider Scoop: Four Stocks Under $3 Seeing Insider Action

The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Insider Moves at Rave Restaurant

• The Trade: Rave Restaurant Group, Inc. RAVE CEO Brandon Solano acquired a total of 11,376 shares at an average price of $1.72, totaling around $19,621.
• What’s Happening: On Feb. 1, RAVE Restaurant Group reported a decline in quarterly sales.
• Company Profile: Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, and express restaurants.

AmeriServ Financial Insider Activity

• The Trade: AmeriServ Financial, Inc. ASRV President & CEO ASRV & Bank Jeffrey A Stopko acquired a total of 2,000 shares at an average price of $2.53, amounting to around $5,060.
• What’s Happening: On Jan. 23, AmeriServ Financial posted a loss for the fourth quarter.
• Business Focus: AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries generate income from banking, bank-related services, and trust-related services.

Check This Out: How To Earn $500 A Month From Apple Stock

Insider Action at Nerdy

• The Trade: Nerdy, Inc. NRDY CEO Charles K. Cohn acquired a total of 67,991 shares at an average price of $2.88, with an insider investment of about $195,814.
• What’s Happening: On March 11, JP Morgan analyst Bryan Smilek initiated coverage on Nerdy with an Overweight rating and a price target of $5.
• Company Overview: Nerdy Inc is a curated direct-to-consumer platform for live online learning.

Stock Movement at Fresh Tracks Therapeutics

• The Trade: Fresh Tracks Therapeutics, Inc. FRTX 10% owner Exploration Capital, LLC acquired a total of 16,329 shares at an average price of $0.92, amounting to around $14,951.
• What’s Happening: The company’s stock declined approximately 8% over the past month.
• Company Description: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing innovative prescription therapeutics to improve patient lives.

Don’t forget to check out our premarket coverage here